000			01699 a2200397 4500
005			20250517201443.0
264		0	_c20190307
008			201903s 0 0 eng d
022			_a1534-4436
024	7		_a10.1016/j.anai.2018.02.004 _2doi
040			_aNLM _beng _cNLM
100	1		_aVerdu, Miriam
245	0	0	_aRapid oral desensitization protocol to abiraterone acetate. _h[electronic resource]
260			_bAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology _c06 2018
300			_a668-669 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article
650	0	4	_aAbiraterone Acetate _xadministration & dosage
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAdrenal Cortex Hormones _xtherapeutic use
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents, Hormonal _xadministration & dosage
650	0	4	_aBone Neoplasms _xdrug therapy
650	0	4	_aChlorpheniramine _xtherapeutic use
650	0	4	_aDesensitization, Immunologic _xmethods
650	0	4	_aDexamethasone _xtherapeutic use
650	0	4	_aDrug Administration Schedule
650	0	4	_aHistamine Antagonists _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aProstatic Neoplasms, Castration-Resistant _xdrug therapy
650	0	4	_aUrticaria _xchemically induced
700	1		_aTorres-Degayon, Virginia
700	1		_aHassan-Bennis, Mohamed
773	0		_tAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology _gvol. 120 _gno. 6 _gp. 668-669
856	4	0	_uhttps://doi.org/10.1016/j.anai.2018.02.004 _zAvailable from publisher's website
999			_c28075631 _d28075631